Loading clinical trials...
Loading clinical trials...
A Natural History Study to Observe Disease Progression, Standard of Care and Investigate Biomarkers in Alport Syndrome Patients
Conditions
Locations
15
United States
San Diego, California, United States
Chicago, Illinois, United States
Minneapolis, Minnesota, United States
St Louis, Missouri, United States
New York, New York, United States
Cleveland, Ohio, United States
Start Date
September 4, 2014
Primary Completion Date
December 18, 2017
Completion Date
December 18, 2017
Last Updated
July 2, 2019
Lead Sponsor
Genzyme, a Sanofi Company
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions